Balanced news tone
News Sentiment
SANO sentiment intelligence
Sanofi news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
50
Balanced news tone
10 relevant articles
News tone and price action are not far from neutral.
81/100 classification confidence.
directly relevant articles
high-authority source matches
+0.4% over one week, -0.7% over four weeks, trend inactive, and near fair-value range.
Sanofi SA (HAM:SNW2) Stock Price, Trades & News
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
81/100 classification
One-week reaction
0.4%
Price digesting
Trend fit
Trend inactive
-0.7% over four weeks
Fair value
-7.3%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
2
Neutral
7
Negative
1
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
GuruFocus
Direct company coverage
Sanofi SA (HAM:SNW2) Stock Price, Trades & News
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jul 2026 08:17
- Source
- GuruFocus
Traders Union
Direct company coverage
Sanofi stock slides as price lingers below the long-term average
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 07:00
- Source
- Traders Union
IndexBox
Direct company coverage
Why Investors Hold Medtronic, Sanofi, and Bristol Myers Squibb for Dividends - News and Statistics
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Apr 2026 07:00
- Source
- IndexBox
CHEManager
Direct company coverage
Sanofi Completes Acquisition of Dynavax for $2.2 Billion
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 10 Feb 2026 08:00
- Source
- CHEManager
CoinCentral
Direct company coverage
Sanofi (SNY) Stock: French Drugmaker Announces €1 Billion Share Buyback Through 2026
- Tone
- Positive 62/100
- Event
- Capital return
- Published
- 03 Feb 2026 08:00
- Source
- CoinCentral
Clinical Trials Arena
Direct company coverage
Sanofi shares fall 6% after double setback for MS drug tolebrutinib
- Tone
- Negative 22/100
- Event
- Market update
- Published
- 15 Dec 2025 08:00
- Source
- Clinical Trials Arena
Clinical Trials Arena
Direct company coverage
Sanofi stock slides on Dupixent successor AD trial
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Sep 2025 07:00
- Source
- Clinical Trials Arena
Pharmaceutical Technology
Direct company coverage
Sanofi kicks off share buyback plan with $3bn L’Oréal stake purchase
- Tone
- Positive 62/100
- Event
- Capital return
- Published
- 03 Feb 2025 08:00
- Source
- Pharmaceutical Technology
CMC Markets
Direct company coverage
Can playing to win after COVID drag lift Sanofi’s share price?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Dec 2021 08:00
- Source
- CMC Markets
Pharmaceutical Technology
Direct company coverage
Regeneron to repurchase $5bn equity stake held by Sanofi
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 26 May 2020 07:00
- Source
- Pharmaceutical Technology